Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (NHPBP) EBT (2016 - 2025)

Historic EBT for National Healthcare Properties (NHPBP) over the last 13 years, with Q3 2025 value amounting to -$12.5 million.

  • National Healthcare Properties' EBT rose 6941.79% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.7 million, marking a year-over-year increase of 7386.43%. This contributed to the annual value of -$190.0 million for FY2024, which is 16360.84% down from last year.
  • According to the latest figures from Q3 2025, National Healthcare Properties' EBT is -$12.5 million, which was up 6941.79% from -$20.8 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare Properties' EBT peaked at -$1.5 million during Q1 2025, and registered a low of -$116.9 million during Q2 2024.
  • Its 5-year average for EBT is -$24.3 million, with a median of -$17.6 million in 2022.
  • As far as peak fluctuations go, National Healthcare Properties' EBT tumbled by 57580.24% in 2024, and later surged by 9017.44% in 2025.
  • Over the past 5 years, National Healthcare Properties' EBT (Quarter) stood at -$19.4 million in 2021, then increased by 3.71% to -$18.7 million in 2022, then tumbled by 32.82% to -$24.8 million in 2023, then surged by 31.85% to -$16.9 million in 2024, then rose by 26.22% to -$12.5 million in 2025.
  • Its EBT stands at -$12.5 million for Q3 2025, versus -$20.8 million for Q2 2025 and -$1.5 million for Q1 2025.